Cargando…
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
SARS‐CoV‐2 variants are now still challenging all the approved vaccines, including mRNA vaccines. There is an urgent need to develop new generation mRNA vaccines with more powerful efficacy and better safety against SARS‐CoV‐2 variants. In this study, a new set of ionizable lipids named 4N4T are con...
Autores principales: | Chen, Kepan, Fan, Na, Huang, Hai, Jiang, Xin, Qin, Shugang, Xiao, Wen, Zheng, Qian, Zhang, Yupei, Duan, Xing, Qin, Zeyi, Liu, Yongmei, Zeng, Jun, Wei, Yuquan, Song, Xiangrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349794/ https://www.ncbi.nlm.nih.gov/pubmed/35942272 http://dx.doi.org/10.1002/adfm.202204692 |
Ejemplares similares
-
A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
por: Qin, Shugang, et al.
Publicado: (2023) -
Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
por: Fan, Na, et al.
Publicado: (2022) -
Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine
por: Duan, Xing, et al.
Publicado: (2023) -
A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma
por: Guo, Mengran, et al.
Publicado: (2023) -
Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
por: Lewis, Mae M., et al.
Publicado: (2023)